Top Markets
Coin of the day
China Medicine Corp. China Medicine Corp.

China Medicine Corp.

CHME
Kedudukan dalam Saham #38472
China Medicine Corporation produces and distributes prescription and over the... China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Harga Saham
$0.0406
Disegerakkan terakhir: 2026-08-13
Modal Pasaran
$962.71K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
6,666.67%
Negara
CN
Perdagangan China Medicine Corp. (CHME)

Kategori

Pendapatan untuk China Medicine Corp. (CHME)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini China Medicine Corp., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi China Medicine Corp. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa